Rapamycin

Hazard statements (CLP)

H351, H361fd

Code

Statements

H351

Suspected of causing cancer

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H361fd: Suspected of damaging fertility. 2) Suspected of damaging the unborn child.

2.2 Label elements

Labelling

Signal word

Warning

Hazard statements

H351 Suspected of causing cancer. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.

Precautionary statements

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.

Supplemental label elements

none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.